Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records

被引:5
|
作者
Campbell, Anne [1 ]
Bailey, Steffani R. [2 ]
Hoffman, Kim A. [3 ]
Ponce-Terashima, Javier [4 ]
Fankhauser, Katie [2 ]
Marino, Miguel [2 ,3 ]
McCarty, Dennis [3 ]
机构
[1] Queens Univ, Sch Social Sci Educ & Social Work, Belfast, ME, North Ireland
[2] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA
[3] Portland State Univ, Sch Publ Hlth, Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd CB669, Portland, OR 97230 USA
[4] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Substance use disorder; cannabis use disorder; electronic health records; psychiatric disorders; MAJOR DEPRESSIVE DISORDER; ANXIETY DISORDERS; MENTAL-HEALTH; RISK; METAANALYSIS; PREVALENCE; DEPENDENCE; PSYCHOSIS; MARIJUANA; SYMPTOMS;
D O I
10.1080/02791072.2020.1747665
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Data from a large network of community health centers connected via a single electronic health record (EHR) system examined associations between psychiatric disorders and documentation of a cannabis-related disorder among patients with reported cannabis use. Participants were adults who had at least one ambulatory visit at a clinic in three states between 1/1/2012 and 12/31/2016 and had either 1) a documented cannabis-related disorder indicated by an ICD-9/10 code on the problem list or encounter list or 2) documentation of cannabis use in the EHR social history section. Clinics included 101,405 patients with either cannabis use recorded in the social history of the EHR (n = 71,660) or a cannabis-related disorder documented in the encounter or problem list (n = 29,745). GEE logistic regression modeling estimated adjusted odds ratios (aOR). Odds of patients having cannabis-related disorder recorded on the encounter or problem list were higher for individuals with depression (aOR = 1.08, 95% CI: 1.04-1.13), anxiety (aOR = 1.16, CI: 1.11-1.21) and bipolar disorder (aOR = 1.16, CI: 1.10-1.23). A diagnosis of schizophrenia increased the odds of a cannabis-related disorder by 62% (aOR = 1.62, CI: 1.48- 1.78). Primary care providers should routinely screen for and document cannabis-related disorders and psychiatric disorders.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 50 条
  • [1] Profiles of individuals with cannabis-related disorders
    Fleury, Marie-Josee
    Grenier, Guy
    Cao, Zhirong
    Huynh, Christophe
    SUBSTANCE ABUSE, 2022, 43 (01) : 855 - 864
  • [2] Cannabis-Related Disorders and Toxic Effects
    Hassouneh, Ala'
    Tambyraja, Andrew L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (09): : 867 - 868
  • [3] Cannabis-Related Disorders and Toxic Effects
    Gorelick, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2267 - 2275
  • [4] Associations between childhood maltreatment and psychiatric disorders: analysis from electronic health records in Hong Kong
    Wong, Rosa S.
    Tung, Keith T. S.
    Ho, Frederick K. W.
    Lee, Tatia M. C.
    Chan, Ko Ling
    Bacon-Shone, John
    Coghill, David
    Man, Kenneth K. C.
    Sham, Pak C.
    Wong, Wilfred H. S.
    Tso, Winnie W. Y.
    Chua, Gilbert T.
    Wong, Ian C. K.
    Ip, Patrick
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [5] Associations between childhood maltreatment and psychiatric disorders: analysis from electronic health records in Hong Kong
    Rosa S. Wong
    Keith T. S. Tung
    Frederick K. W. Ho
    Tatia M. C. Lee
    Ko Ling Chan
    John Bacon-Shone
    David Coghill
    Kenneth K. C. Man
    Pak C. Sham
    Wilfred H. S. Wong
    Winnie W. Y. Tso
    Gilbert T. Chua
    Ian C. K. Wong
    Patrick Ip
    Translational Psychiatry, 12
  • [6] SPECT Imaging in Adults with Cannabis-related Disorders
    Garcia, J.
    Vitale, G.
    Okolichany, R.
    Golden, C. J.
    Amen, D.
    Willeumier, K.
    Taylor, D.
    CLINICAL NEUROPSYCHOLOGIST, 2016, 30 (05) : 770 - 771
  • [7] Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review
    Gorelick, David A.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (42) : 6409 - 6419
  • [8] Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders
    Matsumoto, Toshihiko
    Kawabata, Toshitaka
    Okita, Kyoji
    Tanibuchi, Yuko
    Funada, Daisuke
    Murakami, Maki
    Usami, Takashi
    Yokoyama, Rie
    Naruse, Nobuya
    Aikawa, Yuzo
    Furukawa, Aizo
    Komatsuzaki, Chie
    Hashimoto, Nozomu
    Fujita, Osamu
    Umemoto, Aiko
    Kagaya, Ariyuki
    Shimane, Takuya
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (04) : 332 - 341
  • [9] Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Unusual Cannabis-Related Experiences
    Johnson, Emma C.
    Colbert, Sarah M. C.
    Jeffries, Paul W.
    Tillman, Rebecca
    Bigdeli, Tim
    Karcher, Nicole R.
    Chan, Grace
    Kuperman, Samuel
    Meyers, Jacquelyn L.
    Nurnberger, John I.
    Plawecki, Martin H.
    Degenhardt, Louisa
    Martin, Nicholas G.
    Kamarajan, Chella
    Schuckit, Marc
    Murray, Robin M.
    Dick, Danielle M.
    Edenberg, Howard J.
    D'Souza, Deepak Cyril.
    Di Forti, Marta
    Porjesz, Bernice
    Nelson, Elliot C.
    Agrawal, Arpana
    BEHAVIOR GENETICS, 2022, 52 (06) : 366 - 367
  • [10] CANNABIS AND PSYCHIATRIC DISORDERS
    Loga, Slobodan
    Loga-Zec, Svjetlana
    Spremo, Mira
    PSYCHIATRIA DANUBINA, 2010, 22 (02) : 296 - 297